{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:28:13Z","timestamp":1772119693208,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007880","name":"Associazione Bianca Garavaglia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007880","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Con Lorenzo per Mano"},{"name":"Bimbo Tu"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11060-023-04361-z","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:02:01Z","timestamp":1686888121000},"page":"577-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles"],"prefix":"10.1007","volume":"163","author":[{"given":"Maura","family":"Massimino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Vennarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Buttarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manila","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Minasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Pecori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Ferroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giussani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Schiariti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Schiavello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Biassoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Erbetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Chiapparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luna","family":"Boschetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Gianno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelina","family":"Miele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiorgio","family":"Modena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loris","family":"De Cecco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Pollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Barretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"4361_CR1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"A Gajjar","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D et al (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7:813\u2013820 https:\/\/doi.org\/10.1016\/S1470-2045(06)70867-1","journal-title":"Lancet Oncol"},{"key":"4361_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.critrevonc.2016.05.012","volume":"105","author":"M Massimino","year":"2016","unstructured":"Massimino M, Biassoni V, Gandola L et al (2016) Childhood medulloblastoma. Crit Rev Oncol Hematol 105:35\u201351. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.05.012","journal-title":"Crit Rev Oncol Hematol"},{"key":"4361_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/neuonc\/noaa301","volume":"23","author":"C Dufour","year":"2021","unstructured":"Dufour C, Foulon S, Geoffray A et al (2021) Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR + 5. Neuro Oncol 23:1163\u20131172. https:\/\/doi.org\/10.1093\/neuonc\/noaa301","journal-title":"Neuro Oncol"},{"key":"4361_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1200\/JCO.2008.18.4176","volume":"27","author":"L Gandola","year":"2009","unstructured":"Gandola L, Massimino M, Cefalo G et al (2009) Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 27:566\u2013571. https:\/\/doi.org\/10.1200\/JCO.2008.18.4176","journal-title":"J Clin Oncol"},{"key":"4361_CR5","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ijrobp.2008.06.1930","volume":"73","author":"M Massimino","year":"2009","unstructured":"Massimino M, Gandola L, Spreafico et al (2009) No salvage using high-dose chemotherapy plus\/minus reirradiation for relapsing previously irradiated medulloblastoma. Int J Radiat Oncol Biol Phys 73:1358\u20131363. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.06.1930","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4361_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11060-016-2202-1","volume":"129","author":"M Sabel","year":"2016","unstructured":"Sabel M, Fleischhack G, Tippelt S, SIOP-E Brain Tumour Group et al (2016) Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study. J Neurooncol 129:515\u2013524. https:\/\/doi.org\/10.1007\/s11060-016-2202-1","journal-title":"J Neurooncol"},{"key":"4361_CR7","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/neuonc\/nox109","volume":"19","author":"MW Kieran","year":"2017","unstructured":"Kieran MW, Chisholm J, Casanova M et al (2017) Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma. Neuro Oncol 19:1542\u20131552. https:\/\/doi.org\/10.1093\/neuonc\/nox109","journal-title":"Neuro Oncol"},{"key":"4361_CR8","doi-asserted-by":"publisher","first-page":"5128","DOI":"10.3390\/cancers14205128","volume":"14","author":"I Slavc","year":"2022","unstructured":"Slavc I, Mayr L, Stepien N, Gojo J et al (2022) Improved long-term survival of patients with recurrent Medulloblastoma treated with a \u201cMEMMAT-like. Metronomic Antiangiogenic Approach Cancers (Basel) 14:5128. https:\/\/doi.org\/10.3390\/cancers14205128","journal-title":"Metronomic Antiangiogenic Approach Cancers (Basel)"},{"key":"4361_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41591-020-0827-2","volume":"26","author":"LK Donovan","year":"2020","unstructured":"Donovan LK, Delaidelli A, Joseph SK et al (2020) Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma. Nat Med 26:720\u2013731. https:\/\/doi.org\/10.1038\/s41591-020-0827-2","journal-title":"Nat Med"},{"key":"4361_CR10","doi-asserted-by":"publisher","unstructured":"Winnicki C, Leblond P, Bourdeaut F, Pagnier A et al (2023 Feb) Retrospective National \u201cReal Life\u201d experience of the SFCE with the metronomic MEMMAT and MEMMAT-like protocol. J Clin Med 10(4):1415. https:\/\/doi.org\/10.3390\/jcm12041415","DOI":"10.3390\/jcm12041415"},{"key":"4361_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/cancers14010126","volume":"14","author":"RM Hill","year":"2021","unstructured":"Hill RM, Plasschaert SLA, Timmermann B et al (2021) Relapsed Medulloblastoma in Pre-Irradiated Patients: current practice for Diagnostics and Treatment. Cancers (Basel) 14:126. https:\/\/doi.org\/10.3390\/cancers14010126","journal-title":"Cancers (Basel)"},{"key":"4361_CR12","doi-asserted-by":"publisher","unstructured":"Gaab C, Adolph JE, Tippelt S, Mikasch R et al (2022) Local and systemic therapy of recurrent Medulloblastomas in Children and Adolescents: results of the P-HIT-REZ 2005 study. Cancers (Basel). 14:471. https:\/\/doi.org\/10.3390\/cancers14030471","DOI":"10.3390\/cancers14030471"},{"key":"4361_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11060-021-03842-3","volume":"155","author":"LV Baroni","year":"2021","unstructured":"Baroni LV, Freytes C, Fern\u00e1ndez Ponce N et al (2021) Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma. J Neurooncol 155:53\u201361","journal-title":"J Neurooncol"},{"key":"4361_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11060-019-03272-2","volume":"145","author":"DS Tsang","year":"2019","unstructured":"Tsang DS, Sarhan N, Ramaswamy V et al (2019) Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience. J Neurooncol 145:107\u2013114. https:\/\/doi.org\/10.1007\/s11060-019-03272-2","journal-title":"J Neurooncol"},{"key":"4361_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11060-019-03225-9","volume":"144","author":"T Gupta","year":"2019","unstructured":"Gupta T, Maitre M, Sastri GJ et al (2019) Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping. J Neurooncol 144:283\u2013291. https:\/\/doi.org\/10.1007\/s11060-019-03225-9","journal-title":"J Neurooncol"},{"key":"4361_CR16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ijrobp.2017.07.026","volume":"99","author":"AD Rao","year":"2017","unstructured":"Rao AD, Rashid AS, Chen Q et al (2017) Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: a multi-institutional review. Int J Radiat Oncol Biol Phys 99:634\u2013641. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.026","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4361_CR17","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1002\/cncr.28907","volume":"120","author":"C Wetmore","year":"2014","unstructured":"Wetmore C, Herington D, Lin T, Onar-Thomas A, Gajjar A, Merchant TE (2014) Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity? Cancer 120:3731\u20133737. https:\/\/doi.org\/10.1002\/cncr.28907","journal-title":"Cancer"},{"key":"4361_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"4361_CR19","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1200\/JCO.2011.39.8719","volume":"30","author":"B Lannering","year":"2012","unstructured":"Lannering B, Rutkowski S, Doz F et al (2012) Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol 30:3187\u20133193. https:\/\/doi.org\/10.1200\/JCO.2011.39.8719","journal-title":"J Clin Oncol"},{"key":"4361_CR20","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1200\/JCO.2010.30.2299","volume":"28","author":"S Rutkowski","year":"2010","unstructured":"Rutkowski S, von Hoff K, Emser A et al (2010) Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 28:4961\u20134968. https:\/\/doi.org\/10.1200\/JCO.2010.30.2299","journal-title":"J Clin Oncol"},{"key":"4361_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00401-011-0800-8","volume":"121","author":"DW Ellison","year":"2011","unstructured":"Ellison DW, Dalton J, Kocak M et al (2011) Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH\/WNT molecular subgroups. Acta Neuropathol 121:381\u2013396. https:\/\/doi.org\/10.1007\/s00401-011-0800-8","journal-title":"Acta Neuropathol"},{"key":"4361_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.5858\/2002-126-0540-MAMOAI","volume":"126","author":"N Aldosari","year":"2002","unstructured":"Aldosari N, Bigner SH, Burger PC et al (2002) MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children\u2019s Oncology Group. Arch Pathol Lab Med 126:540\u2013544. https:\/\/doi.org\/10.5858\/2002-126-0540-MAMOAI","journal-title":"Arch Pathol Lab Med"},{"key":"4361_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-012-1077-2","volume":"125","author":"EC Schwalbe","year":"2013","unstructured":"Schwalbe EC, Williamson D, Lindsey JC et al (2013) DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol 125:359\u2013371. https:\/\/doi.org\/10.1007\/s00401-012-1077-2","journal-title":"Acta Neuropathol"},{"key":"4361_CR24","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00381-021-05199-4","volume":"37","author":"S Avula","year":"2021","unstructured":"Avula S, Peet A, Morana G, Morgan P, Warmuth-Metz M, Jaspan T (2021) European Society for Paediatric Oncology (SIOPE)-Brain Tumour Imaging Group. European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours. Childs Nerv Syst 37:2497\u20132508. https:\/\/doi.org\/10.1007\/s00381-021-05199-4","journal-title":"Childs Nerv Syst"},{"key":"4361_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/neuonc\/nox087","volume":"20","author":"KE Warren","year":"2018","unstructured":"Warren KE, Vezina G, Poussaint TY et al (2018) Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol 20:13\u201323. https:\/\/doi.org\/10.1093\/neuonc\/nox087","journal-title":"Neuro Oncol"},{"key":"4361_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","volume":"8","author":"S Durrleman","year":"1989","unstructured":"Durrleman S, Simon R (1989) Flexible regression models with cubic splines. Stat Med 8:551\u2013561","journal-title":"Stat Med"},{"key":"4361_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11060-012-0822-7","volume":"108","author":"M Massimino","year":"2012","unstructured":"Massimino M, Cefalo G, Riva D et al (2012) Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma. J Neurooncol 108:163\u2013171. https:\/\/doi.org\/10.1007\/s11060-012-0822-7","journal-title":"J Neurooncol"},{"key":"4361_CR28","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.ijrobp.2007.08.015","volume":"70","author":"R Mayer","year":"2008","unstructured":"Mayer R, Sminia P (2008) Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 70:1350\u20131360. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.08.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4361_CR29","doi-asserted-by":"publisher","unstructured":"Tsang DS, Laperriere NJ (2019) Re-irradiation for paediatric tumours. Clin Oncol (R Coll Radiol). 31:191\u2013198. https:\/\/doi.org\/10.1016\/j.clon.2018.10.003","DOI":"10.1016\/j.clon.2018.10.003"},{"key":"4361_CR30","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1002\/cncr.26148","volume":"117","author":"RL Bakst","year":"2011","unstructured":"Bakst RL, Dunkel IJ, Gilheeney S et al (2011) Reirradiation for recurrent medulloblastoma. Cancer 117:4977\u20134982. https:\/\/doi.org\/10.1002\/cncr.26148","journal-title":"Cancer"},{"key":"4361_CR31","doi-asserted-by":"publisher","unstructured":"Massimino M, Casanova M, Polastri D, Biassoni V, Modena P, Pecori E, Schiavello E, De Pava MV, Indini A, Rampini P, Bauer D, Catania S, Podda M, Gandola L (2013 Jul) Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience. Childs Nerv Syst 29(7):1107\u20131112. https:\/\/doi.org\/10.1007\/s00381-013-2104-x","DOI":"10.1007\/s00381-013-2104-x"},{"key":"4361_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJM199403313301303","volume":"330","author":"CF Torres","year":"1994","unstructured":"Torres CF, Rebsamen S, Silber JH et al (1994) Surveillance scanning of children with medulloblastoma. N Engl J Med 330:892\u2013895. https:\/\/doi.org\/10.1056\/NEJM199403313301303","journal-title":"N Engl J Med"},{"key":"4361_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/mpo.1278","volume":"38","author":"B Yal\u00e7in","year":"2002","unstructured":"Yal\u00e7in B, B\u00fcy\u00fckpamuk\u00e7u M, Akalan N, Cila A, Kutluk MT, Aky\u00fcz C (2002) Value of surveillance imaging in the management of medulloblastoma. Med Pediatr Oncol 38:91\u201397. https:\/\/doi.org\/10.1002\/mpo.1278","journal-title":"Med Pediatr Oncol"},{"key":"4361_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3171\/jns.2003.99.2.0280","volume":"99","author":"DE Saunders","year":"2003","unstructured":"Saunders DE, Hayward RD, Phipps KP, Chong WK, Wade AM (2003) Surveillance neuroimaging of intracranial medulloblastoma in children: how effective, how often, and for how long? J Neurosurg 99:280\u2013286. https:\/\/doi.org\/10.3171\/jns.2003.99.2.0280","journal-title":"J Neurosurg"},{"key":"4361_CR35","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2001.19.21.4135","volume":"19","author":"AY Minn","year":"2001","unstructured":"Minn AY, Pollock BH, Garzarella L et al (2001) Surveillance neuroimaging to detect relapse in childhood brain tumors: a Pediatric Oncology Group study. J Clin Oncol 19:4135\u20134140. https:\/\/doi.org\/10.1200\/JCO.2001.19.21.4135","journal-title":"J Clin Oncol"},{"key":"4361_CR36","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1200\/JCO.20.01359","volume":"39","author":"R Kumar","year":"2021","unstructured":"Kumar R, Smith KS, Deng M et al (2021) Clinical outcomes and patient-matched molecular composition of relapsed Medulloblastoma. J Clin Oncol 39:807\u2013821. https:\/\/doi.org\/10.1200\/JCO.20.01359","journal-title":"J Clin Oncol"},{"key":"4361_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tig.2020.11.001","volume":"37","author":"J Garcia-Lopez","year":"2021","unstructured":"Garcia-Lopez J, Kumar R, Smith KS, Northcott PA (2021) Deconstructing Sonic hedgehog medulloblastoma: Molecular Subtypes, Drivers, and Beyond. Trends Genet 37:235\u2013250. https:\/\/doi.org\/10.1016\/j.tig.2020.11.001","journal-title":"Trends Genet"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04361-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T10:08:07Z","timestamp":1690884487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04361-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4361"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04361-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2899535\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}